RNA sequencing and multiplexed immunohistochemistry reveal the factors for postoperative recurrence of stage IB-IIA cervical squamous cell carcinoma

Bibliographic Details
Title: RNA sequencing and multiplexed immunohistochemistry reveal the factors for postoperative recurrence of stage IB-IIA cervical squamous cell carcinoma
Authors: Meiyao Wu, Baixue Li, Lina Shi, Lingling Yang, Chuqiao Liang, Tianhong Wang, Xiujie Sheng
Source: Discover Oncology, Vol 15, Iss 1, Pp 1-10 (2024)
Publisher Information: Springer, 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Cervical cancer, RNA sequencing, Multiplexed immunohistochemistry, Immune cell, Prognosis biomarkers, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background Stage IB-IIA Cervical Squamous Cell Carcinoma (CSCC) presents diverse clinical outcomes, the mechanisms that cause recurrence in CC patients remain unclear. The goal of this study was to identify predictive biomarkers leading to tumor recurrence in IB-IIA CSCC after surgical treatment by comparing the transcriptional and immune landscape between the recurrence and non-recurrence group. Methods We performed mRNA sequencing and multiplexed immunohistochemistry (mIHC) analysis among stage IB-IIA patients with or without recurrence after surgical resection and were followed-up for a median of three years. Results Integrated analysis indicates that the upregulated gene expression in zinc finger proteins, the activation of the PI3K/Akt pathway, and the low infiltration level of T follicular helper cells and B-cells may serve as potential recurrent biomarkers for CSCC. We also observed significant differences in the immune and genomic landscape between two groups. Conclusions These findings provide new insights into the relapse mechanisms of CSCC, which could potentially guide clinical exploration of drug targets.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2730-6011
Relation: https://doaj.org/toc/2730-6011
DOI: 10.1007/s12672-024-01283-8
Access URL: https://doaj.org/article/c7d77777fe884832ab018518223c0802
Accession Number: edsdoj.7d77777fe884832ab018518223c0802
Database: Directory of Open Access Journals
More Details
ISSN:27306011
DOI:10.1007/s12672-024-01283-8
Published in:Discover Oncology
Language:English